OBJECTIVE: To describe trends in opioid consumption in Israel (morphine, methadone, oxycodone, pethidine, fentanyl, buprenorphine, codeine, and dextropropoxyphene) over the 9 years, 2000-2008, and to explore explanations for changes in consumption, in amounts and the pattern. METHODS: Data for the 2000-2008 period (all treatment settings, private and public) were drawn from the database maintained by the Israel Ministry of Health's Pharmaceutical Administration. The data were converted into a defined daily dose (DDD)/1,000 inhabitants/day. RESULTS: Consumption of the five strong opioids (requiring a special prescription form) increased by 47%, from 2.46 DDD/1,000 inhabitants per day in 2000 to 3.61 DDD/1,000 inhabitants per day in 2008. This rise was mainly the result of a 4-fold increase in fentanyl consumption from 0.32 DDD/1,000 inhabitants per day in 2000 to 1.28 DDD/1,000 inhabitants per day in 2008. Oxycodone and methadone consumption levels increased moderately, and buprenorphine and dextropropoxyphene consumption rose drastically, whereas morphine, pethidine, and codeine use significantly fell. CONCLUSION: There has been a modest increase in opioid consumption in the years 2000-2008. This has been associated with substantial changes in the pattern of differential opioid prescribing characterized by increased prescription of oxycodone, fentanyl, buprenorphine, and dextropropoxyphene, and decreases in morphine, pethidine, and codeine.
OBJECTIVE: To describe trends in opioid consumption in Israel (morphine, methadone, oxycodone, pethidine, fentanyl, buprenorphine, codeine, and dextropropoxyphene) over the 9 years, 2000-2008, and to explore explanations for changes in consumption, in amounts and the pattern. METHODS: Data for the 2000-2008 period (all treatment settings, private and public) were drawn from the database maintained by the Israel Ministry of Health's Pharmaceutical Administration. The data were converted into a defined daily dose (DDD)/1,000 inhabitants/day. RESULTS: Consumption of the five strong opioids (requiring a special prescription form) increased by 47%, from 2.46 DDD/1,000 inhabitants per day in 2000 to 3.61 DDD/1,000 inhabitants per day in 2008. This rise was mainly the result of a 4-fold increase in fentanyl consumption from 0.32 DDD/1,000 inhabitants per day in 2000 to 1.28 DDD/1,000 inhabitants per day in 2008. Oxycodone and methadone consumption levels increased moderately, and buprenorphine and dextropropoxyphene consumption rose drastically, whereas morphine, pethidine, and codeine use significantly fell. CONCLUSION: There has been a modest increase in opioid consumption in the years 2000-2008. This has been associated with substantial changes in the pattern of differential opioid prescribing characterized by increased prescription of oxycodone, fentanyl, buprenorphine, and dextropropoxyphene, and decreases in morphine, pethidine, and codeine.
Authors: Alexander M Ponizovsky; Alexander Grinshpoon; Anatoly Margolis; Rami Cohen; Paula Rosca Journal: Addict Behav Date: 2006-03-09 Impact factor: 3.913
Authors: Javier Garcia del Pozo; Alfonso Carvajal; Jose Maria Viloria; Alfonso Velasco; Victorina Garcia del Pozo Journal: Eur J Clin Pharmacol Date: 2007-12-20 Impact factor: 2.953
Authors: Alexander M Ponizovsky; Anatoly Margolis; Ludmila Heled; Paula Rosca; Irena Radomislensky; Alexander Grinshpoon Journal: Subst Use Misuse Date: 2010 Impact factor: 2.164
Authors: M Silbermann; M Arnaout; M Daher; S Nestoros; B Pitsillides; H Charalambous; M Gultekin; R Fahmi; K A H Mostafa; A D Khleif; N Manasrah; A Oberman Journal: Ann Oncol Date: 2012-04 Impact factor: 32.976
Authors: Elizabeth A Wright; Jeffrey N Katz; Stanley Abrams; Daniel H Solomon; Elena Losina Journal: Arthritis Care Res (Hoboken) Date: 2014-10 Impact factor: 4.794
Authors: Rishi J Desai; Krista F Huybrechts; Sonia Hernandez-Diaz; Helen Mogun; Elisabetta Patorno; Karol Kaltenbach; Leslie S Kerzner; Brian T Bateman Journal: BMJ Date: 2015-05-14
Authors: Prasad S Nishtala; Sekbong Oh; Daniel Kim; Natalie Chun; Siti Fatimah Binti Kamis; Kuan-Cia Kiu Journal: Drugs Real World Outcomes Date: 2015-06